Header image

CLINICAL: Snores and scales: Tackling obesity and OSA

Tracks
Track 2
Saturday, October 11, 2025
11:00 AM - 12:30 PM

Details

Obesity is a major risk factor for obstructive sleep apnea (OSA), contributing to airway obstruction, reduced lung function, and increased disease severity. This session will explore the complex relationship between obesity and OSA, highlighting the physiological mechanisms linking excess weight to sleep-disordered breathing. Attendees will gain insights into the impact on cardiovascular health, metabolic disorders, and quality of life. The session will also review the latest advancements in weight management strategies, including lifestyle interventions, bariatric surgery, and pharmacological treatments such as GLP-1 receptor agonists.


Speaker

Danny Eckert

OSA and obesity: Nuts and bolts (epidemiology and endotypes/phenotypes)

11:00 AM - 11:20 AM

Biography

Samantha Hocking

Obesity and weight loss: Endocrinologist/obesity physician point of view

11:20 AM - 11:40 AM

Biography

Prof Matthew Naughton
Head, Sleep Service
Alfred Hospital / Monash University

Obesity and weight loss in OSA: Sleep physician point of view

11:40 AM - 12:00 PM

Biography

Agenda Item Image
Dr Sanjay Patel
Professor, Medicine, Epidemiology, Clinical & Translational Science
University of Pittsburgh

Should GLP-1 agonists be first line therapy in obese OSA patients?

12:00 PM - 12:20 PM

Biography

Prof Ron Grunstein
Professor
The Woolcock Institute of Medical Research

Panel discussion with all speakers

12:20 PM - 12:30 PM

Biography

Brendon Yee
Royal Prince Alfred Hospital/Woolcock Institute of Medical Research and Sydney University

Chair

Biography

Craig Phillips

Chair

Biography

loading